Aisling Capital Management LP GLUE Holdings History
Aisling Capital Management LP's Monte Rosa Therapeutics Inc Holding Summary
As of 2025-03-31, Aisling Capital Management LP held 1.47 Mil shares of Monte Rosa Therapeutics Inc(GLUE), totaling $6.83 Mil. This investment constitutes 2.37% of their stock portfolio, and Aisling Capital Management LP now holds 2.39% of the outstanding Monte Rosa Therapeutics Inc(GLUE) stock.
The initial trade took place in 2021Q2. And since then Aisling Capital Management LP has made 1 purchases of GLUE, at an average price of $20.37, for a total of 1.47 Mil shares. Based on historical transaction data and GLUE's current price of $4.59, Aisling Capital Management LP's estimated gain on his GLUE holdings is $-23.23 Mil, reflecting a -77.47% gain to date.
Aisling Capital Management LP GLUE ($4.59) Holding Chart
Aisling Capital Management LP GLUE ($4.59) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
